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Abstract
Human respiratory syncytial virus (HRSV) is the main cause of acute lower respiratory infections in children under 2 years of
age and causes repeated infections throughout life. We investigated the genetic variability of RSV-A circulating in Ontario
during 2010–2011 winter season by sequencing and phylogenetic analysis of the G glycoprotein gene. Among the 201
consecutive RSV isolates studied, RSV-A (55.7%) was more commonly observed than RSV-B (42.3%). 59.8% and 90.1% of
RSV-A infections were among children #12 months and #5 years old, respectively. On phylogenetic analysis of the second
hypervariable region of the 112 RSV-A strains, 110 (98.2%) clustered within or adjacent to the NA1 genotype; two isolates
were GA5 genotype. Eleven (10%) NA1-related isolates clustered together phylogenetically as a novel RSV-A genotype,
named ON1, containing a 72 nucleotide duplication in the C-terminal region of the attachment (G) glycoprotein. The
predicted polypeptide is lengthened by 24 amino acids and includes a23 amino acid duplication. Using RNA secondary
structural software, a possible mechanism of duplication occurrence was derived. The 23 amino acid ON1 G gene
duplication results in a repeat of 7 potential O-glycosylation sites including three O-linked sugar acceptors at residues 270,
275, and 283. Using Phylogenetic Analysis by Maximum Likelihood analysis, a total of 19 positively selected sites were
observed among Ontario NA1 isolates; six were found to be codons which reverted to the previous state observed in the
prototype RSV-A2 strain. The tendency of codon regression in the G-ectodomain may infer a decreased avidity of antibody
to the current circulating strains. Further work is needed to document and further understand the emergence, virulence,
pathogenicity and transmissibility of this novel RSV-A genotype with a72 nucleotide G gene duplication.
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Introduction
Human Respiratory Syncytial virus (RSV) is the major cause of
lower respiratory tract infection (LRTI) in infants and young
children, and is also responsible for a significant proportion of RTIs
in the elderly. It causes repeated infections throughout life due to
limited immune protection from earlier RSV exposure [1,2,3].
RSV, classified in the Pneumovirus genus of the Paramyxoviridae
family, is an enveloped virus with a negative-sense single-stranded
RNA genome which encodes for 11 proteins. Two groups, RSV-A
and RSV-B, have been described on the basis of reactions with
monoclonal antibodies against the G and F glycoproteins [4,5] and
molecular differences of several genes [3]. Being major surface
glycoproteins, G and F are mainly involved in virus attachment to
cell receptors and mediation of cell membrane fusion, respectively
[6,7]. Hence, both proteins are highly accessible to neutralizing
antibodies, with resultant accumulation of mutations in response to
host immunological pressure [8].
RSV-A and RSV-B evolved separately at different time periods
[5]. They co-circulate and both are responsible for epidemics,
which are more commonly caused by RSV-A [9]. Genotyping of
RSV-A and RSV-B viruses is based on the sequence variability of
the G protein gene. Ten RSV-A genotypes have been reported
from different geographical regions, and designated as GA1 to
GA7 [10,11], SAA1 (South Africa, A1) [12] and most recently,
NA1 and NA2 [13]. RSV-B genotypes include GB1 to GB4 [10],
SAB1 to SAB3 [12], and BA1 to BA6 (Buenos Aires) [14].
Interestingly, strains belonging to the BA genotype of RSV-B
from Argentina exhibited a 60 nucleotide (nt) duplication in the
second variable region of the G protein gene but have not caused
any major outbreaks or been associated with serious clinical
manifestations [15,16,17]. Genetic variability between RSV
strains is a signature characteristic that may alter the pathoge-
nicity and fitness of the virus, and contribute to the ability to
cause repeated infections and outbreaks by immune system
evasion.
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consisting of the cytoplasmic tail (amino acids [AAs] 1–38),
transmembrane domain (AA 38–66), and the ectodomain (AA 66–
298). The C-terminal ectodomain of G protein is comprised of 2
variable regions flanking the putative receptor binding site, a
conserved region of 13 AAs (AA 164–176) situated between them.
Although the G protein is highly glycosylated with N- and O-
linked sugars, these positions are poorly conserved [18]. The two
variable regions of the ectodomain contain high serine and
threonine residues, which are potential acceptor sites for O-linked
sugars. These N-and O-linked oligosaccharides contribute to the
antigenic structure of the G protein as well as impacting on virus
infectivity [19,20].
In this study we evaluated the genetic variability in the G
protein gene of RSV-A viruses isolated from clinical samples
collected in Ontario, Canada. Phylogenetic analysis was per-
formed to establish the relationships between Ontario’s strains and
previously described RSV-A genotypes deposited in Genbank. In
depth positive selection pressure analysis was also done to examine
the replacement behavioural patterns of G protein gene encoded
AAs. Further, we tried to derive a possible mechanism for the
occurrence of an observed G gene duplication by viral RNA
secondary structure analysis.
Materials and Methods
Ethics Statement
This study was considered exempt from University of Toronto’s
Health Sciences Research Ethics Board review as it involved
deidentified respiratory tract samples that were tested as part of a
clinical virology service provided by Public Health Ontario
Laboratories. All test-positive samples and a proportion of test-
negative samples are stored for possible further laboratory-based
surveillance work. Samples and isolates included in this study were
analyzed as part of the routine respiratory viral molecular
surveillance program that supports Ontario’s Ministry of Health
and Long-Term Care.
Specimen collection and viral isolates
Public Health Ontario performs a large proportion of primary
respiratory viral testing for the province of Ontario from a variety
of clinical settings including ambulatory, hospital and outbreaks.
All consecutive HRSV culture isolates, identified from November
2010 to February 2011 at Public Health Ontario Laboratory –
Toronto (PHOL), were selected for this study. . Following the
testing algorithm for respiratory specimens, nasopharyngeal swabs
were forwarded directly to PHL for respiratory viral testing. All
nasopharyngeal swabs (NPS) from ambulatory and hospitalized,
non-ICU patients are cultured for virus isolation in two cell lines,
1. either rhesus monkey kidney (RMK) or African green monkey
kidney cells (AGMK), along with 2. WI-38 human embryonic lung
fibroblast (Diagnostic Hybrids, Inc, Ohio, USA). Cell lines
showing cytopathic effect are stained with a blend of murine
monoclonal antibodies (MAbs) directed against seven respiratory
viruses plus separate DFA Reagents, each consisting of MAb
blends directed against a single respiratory virus, including RSV
(D3 Ultra
TM DFA Respiratory Virus Screening & ID Kit,
Diagnostics Hybrids, Ohio, USA). In addition to viral culture,
all NPS from infants under 12 months of age with bronchiolitis or
pneumonia, and when requested in children #5 years of age, are
initially screened by a rapid RSV antigen test (BinaxNOWH RSV
kit, Binax Inc., Maine, USA). Samples submitted from patients in
the outbreak or intensive care unit (ICU) setting undergo multiplex
molecular testing for respiratory viruses, but not viral culture, and
were not evaluated in this study
RNA extraction and sub-grouping
Total nucleic acid was extracted from 250 ul of the supernatant
of each cell-cultured sample using the NucliSens easyMAG
extraction system (bioMe ´rieux Canada Inc. Que ´bec, Canada)
according to manufacturer’s instructions. Sub-grouping was
undertaken targeting the nucleocapsid (N) gene using a modified
duplex version of a previously published method [21].
RT-PCR and Sequencing
A 900-bp fragment of the G gene and a 500-bp fragment of the
F gene of RSV-A was amplified with the OneStep RT-PCR kit
(QIAGEN). Primer G267 corresponds to bases 247 to 267 in the G
glycoprotein of the A2 strain (Genbank accession number
M11486) and F164 primer complementary to bases 164 to 186
in the F protein [22]. Sanger sequencing of the PCR products was
carried out with the same primer pair used for amplifications on
the 37306l DNA sequencer (Applied Biosystems) using the BigDye
Terminator v3.1 cycle sequencing kit (Applied Biosystems).
Alternatively, RSV-A-655F primer [23] was used to amplify the
C-terminal half of the G protein gene when primer G267 did not
yield a good sequence.
Phylogenetic analysis
The nucleotide sequences of a fragment of the second
hypervariable region of G glycoprotein gene (264 nucleotides
corresponding to codon positions 210 to 298) from RSV-A isolates
were determined and compared with those of reference strains
representing different RSV-A genotypes deposited in Genbank.
Sequence editing was performed using Vector NTIH Express
Software (Life Technologies
TM, California, USA). Multiple
sequence alignments of the 264 nucleotides in the second
hypervariable region of G gene compared to available reference
genotypes were performed by the ClustalW algorithm. Phyloge-
netic analyses using the neighbor-joining method, and the
statistical significance of the tree topology tested by bootstrapping
(1,000 replicates) were performed using the MEGA 5.05 software
[24]. The evolutionary distances were derived using the Kimura-2
parameter method [25]. The phylogeny of the partial Fusion (F)
gene sequences was also constructed.
Selection pressure analysis
In order to understand the selection pressure at codon sites, we
used the multiple aligned dataset of all Ontario G-gene (C-
terminal hypervariable region) sequences including NA1 as a
reference sequence and the maximum likelihood (ML) tree as
input for the CODEML program of Phylogenetic Analysis by
Maximum Likelihood (PAML 4.4 version) [26,27]. The program
PAML incorporates different codon-based substitution models that
account for variable v (non-synonymous/synonymous ratio, dN/
dS) for each codon site. In this analysis, we used four different
codon substitution models that account for neutral (M1a and M7)
and positive (M2a and M8) selection. The model M1a estimates a
class of negatively selected sites with proportion p0, with v0=0,
and the remaining sites with proportion p1 (p1=12p0), assuming
v1=1. The M2a model facilitates detection of an extra class of
sites under positive selection with proportion p2 (where
p2=12p12p0) with v1.1. The model M7 incorporates a beta
distribution (with parameters p and q) to account for variable v
among neutral or negatively selected sites. The model M8, allows
positively selected sites with proportion p2, with v2.1. Likelihood
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M8) were conducted by comparing twice the difference in log-
likelihood values (2Dl) against a chi-square distribution with two
degrees of freedom (d.f.) equal to the difference in the number of
parameters between models [26,27] . If the LRT is significant
(p,0.0001), positive selection (v=dN/dS ratio) is inferred. Bayes
Empirical Bayes (BEB) approach (implemented in CODEML) was
used to calculate the posterior probabilities (that takes sampling
errors into account) of the inferred positively selected sites [28].
Sites with high posterior probabilities (P) coming from the class
with v.1( P .95%) are inferred to be under positive selection.
N- and O-glycosylation site analysis
Potential N-glycosylation (Asn-Xaa-Ser/Thr) and O-glycosyla-
tion sites were predicted using NetNGlyc 1.0 [29] and NetOGlyc
3.1 [30]. The deduced AA sequences of the second hypervariable
region of HRSV-A strains (encompassing AA 210 to the end of the
G protein) were compared to those of RSV-A2 and NA1 strains.
RNA secondary structure and analysis
RNA secondary structures were predicted using the MFOLD
web server [31] to compare the relative structural stability of viral
RNA (vRNA) and antigenomic RNA (cRNA). Further analysis of
vRNA secondary structures was done by using a software tool,
‘mfg’, available at http://www.dbs.umt.edu/research_labs/
wrightlab/upload/mfg.html [32]. In a given window size ‘mfg’
folds all nucleotides successively, beginning with each base and
predicts the most stable (2DG) stem loop structures (SLS), in
which that base is unpaired. 2DG represents the negative free
energy. A more negative DG value suggests higher stability in the
SLS. Mfg calculates the frequency with which a specific base is
unpaired in the most stable SLS, giving the result as a ‘‘percent
unpaired’’. A base is called unpaired or paired when present in the
loop or in the stem, respectively.
Genbank nucleotide sequence accession numbers
Representative sequences of RSV-A isolates obtained in this
study have been submitted to Genbank under accession numbers
JN257682–JN257692 for G-gene and JN257693–JN257703 for F-
gene sequences.
Results
Clinical specimens and Isolates
Two hundred and three consecutive RSV-positive NPS
specimens were identified at PHL between November 2010 and
February 2011 from non-ICU, non outbreak patients. Of these,
four were positive by the RSV rapid test but were RSV-negative
by culture and PCR, and excluded from the study. Among the 199
consecutive RSV isolates included in this study, 47 (23.6%) were
obtained from patients reviewed in the emergency room but not
hospitalized, 80 (40.2%) collected from hospitalized (non ICU)
patients and 21 (10.6%) collected from an ambulatory community
setting. There were no data available for the remaining 55 (28%)
specimens. RSV-A and B co-infection was identified in 2 samples,
which were not evaluated further. One hundred and twelve
(55.7%) and 85 (42.3%) of the remaining 197 isolates were
identified as subgroup A and B, respectively. Among RSV-A
positive specimens, 67 (59.8%) were from infants below 12 months
of age, 23 (20.5%) from children 12 to 24 months old, 11 (9.8%)
from children 3 to 5 years of age, and 4 (3.6%) were from children
of 6 to 10 years of age. Only 2 and 5 isolates were obtained from
adults 51 to 66 and 68 to 100 years of age, respectively.
Molecular analysis of RSV-A strains
By comparing the nucleotide composition and the pattern of
mutations among the 112 RSV-A isolates, two major clusters
comprising several groups of identical sequences were identified.
The alignment of deduced AAs of representative isolates for each
group is shown in figure 1. Two previously described genotypes
were identified to be currently circulating in Ontario, with 99
(88.4%) belonging to genotype NA1, which is genetically close to
GA2 strains [13]. Two isolates were closely related to genotype
GA5. A unique observation was the presence of a novel RSV-A
genotype (named ON1) including 11 (10%) of the RSV-A isolates
which contain a 72 nucleotide duplication (GTCAAGAG-
GAAACCCTCCACTCAACCACCTCCGAAGGCTATCTAA-
GCCCATCACAAGTCTATACAACATCCG) in the C-terminal
end of the G gene. The duplication starts after residue 850 of the
G gene (RSV-A2 prototype numbering) and appears to disrupt the
codon ‘‘GAG’’ (residue 850–852) coding for E284, switching it to
‘‘GGT’’ and coding for G284, which is followed by a duplication
of 23 AAs (QEETLHSTTSEGYLSPSQVYTTS) spanning posi-
tions 261–283 and 285–307 (Figure 2). Although this in-frame
duplication does not cause a frame shift, the predicted polypeptide
is lengthened by 24 AAs when compared to the reference NA1
genotype. The presence of the G gene duplication was confirmed
in the primary specimens of all 10 isolates in which it was detected
The G gene sequence of the Ontario NA1 isolates is closely
related to the reference NA1 genotype (AB470478), sharing a high
homology of 94.2–98.8% at the nucleotide level and 89.5–98.8%
at the amino acid level. However, these ratios dropped to 75.4%
and 72.7% at the nucleotide and AA levels, respectively, for ON1
novel RSV-A genotype sequences. Ontario’s NA1 and ON1
strains displayed an early stop codon at positions 298 and 322,
respectively, when compared to the prototype RSV-A2 strain.
Homology between members of the novel RSV-A ON1
genotype was between 99–100% and 3 unique substitutions,
E232G, T253K and P314L (P290L if the duplication is removed),
were noted to be specific for this group and not observed in other
isolates. Compared to the reference RSV-A2 strain, 16 G gene
amino acid substitutions were identified universally among
Ontario’s NA1 and ON1 strains including S222P, P226L,
E233K, N237D, I244R, L258H, M262E, F265L/P/H, S269T,
N273Y, P274L, S280Y, P283S, P286L, P289S, S290P/L, P292S,
P293S, P296T, and R297K.
The nucleotide sequence of the G gene from the ON1 genotype
is translated to a polypeptide of 322 AAs, the largest found so far
among RSV-A isolates. The central domain, HFEVFNFVPC-
SICSNNPTCWAIC , remained conserved among all of Ontario’s
RSV-A isolates (Figure 2).
Only 2 (1.8%) of the RSV-A isolates, ON/RSV89 and ON/
RSV181, were closely related to the GA5 genotype, sharing
homology of 94.6%–95.4% at the nucleotide level and 91.9% at
the amino acid level with the reference GA5 strain TX67951.
They contained several unique mutations including N237Y,
S270F, V279I, N297D and H298Q.
Phylogenetic analysis
Representative sequences of RSV-A strains circulating in
Ontario along with 23 reference strains of RSV-A genotype
derived from Genbank were included in the phylogenetic analysis
(Figure 3a). Sequencing and phylogenetic analysis shows that the
Ontario RSV-A genotypes were classified into three genotypes:
NA1, GA5, and a novel genotype, ON1. The two GA5 isolates
clustered with a bootstrapping value of 99%. All Ontario NA1
isolates clustered with NA1 genotype (AB470478) with boot-
strapping value of 89%. Ontario NA1 isolates were further divided
A Novel Genotype of HRSV A in Ontario, Canada
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share $96% nucleotide similarity and can be designated as
individual subtypes of genotype NA1, as proposed by Peret et al
[10]. All members of novel ON1 clustered together creating an
individual branch with bootstrap value of 94% and p-distance of
0.04. This meets the proposed criteria for a new genotype – a
cluster of sequences with bootstrap values of 70%–100% and a p
distance of #0.07. [12].
Comparing the F gene phylogeny of the study RSV-A isolates
based on a 500 nucleotide partial sequence (nucleotides 700–1200;
Figure 3b) reveals agreement between the two data sets, with the
ON1 genotype again clustering as an individual branch. Neverthe-
less, due to the lower nucleotide variability, the phylogenetic tree of
the F gene region showed less resolution than that of the G gene.
Although genetic and antigenic variations occur more frequently in
the G protein than F protein, the similarity of both trees confirm the
observations drawn from the G gene phylogenetic analysis.
Glycosylation sites
Different patterns of putative O- and N-glycosylation sites were
seen among Ontario isolates. Twenty one and 27 O-glycosylation
sites were predicted in ON/RSV89 and ON/RSV181 (GA5
genotype isolates) respectively, whereas 3362 sites were potentially
O-glycosylated (G scores of 0.5–0.8) in Ontario NA1 isolates
(Figure 1). All ON1 strains shared a similar profile of O-
glycosylation and contained the highest number of O-glycosylation
with 37 to 40 predicted sites. The 23AA duplication resulted in
duplication of 7 potential O-glycosylation sites. The previously
reported AA positions (serine at 267, 270, 275, 283, 287 and
threonine at 227, 231, 235, 253, and 282) that are likely to have O-
linked side chains were conserved in all Ontario isolates [8]. In
addition, AAs 270, 275 and 283 were repeated in the duplicated
region of ON1 isolates. By analysing the same region using
NetNGlyc 1.0 server [29], four putative N-glycosylation sites (Asn-
X-Ser/Thr) were identified among Ontario circulating strains. Only
one of four N-glycosylation sites (AA 294 in RSV-A2 strain or AA
318 in the ON1 strains) remains conserved between all Ontario’s
isolates and RSV-A isolates deposited in Genbank. When compared
to the NA1 reference strain (AB470478), two AA substitutions
(T253K and N273Y) were observed among ON1 isolates, which led
to loss of 2 potential N-glycosylation sites (Figure 1).
Selective pressure analysis
Relative contributions of selective forces on the evolution of the
C-terminal hypervariable region of G-proteins of RSV-A were
assessed by measuring the site-specific dN/dS using the PAML
program. The average dN/dS ranged from 0.355 to 0.960 among
all codon substitution models (Table 1). The M2a and M8 models
provide a significantly (p,0.0001) better fit to the dataset as
evaluated by the likelihood ratio tests (LRTs) than do their
counterpart models, M1a and M7 respectively. Both the M8 and
M2a models suggested the presence of positively selected sites with
a proportion ranging from 15.99% (p2=0.1599 with v2=4.4946)
to 17.09% (p2=0.1709 with v2=4.2356). A total of nineteen
Figure 1. Alignment of deduced amino acid sequence of the G protein of RSV-A strains isolated in Ontario during the 2010–2011
winter season. Alignments are shown relative to the sequences of prototype strain A2 and genotype NA1 strain (AB470478). The AAs shown
correspond to positions 201 to 298 of the second hypervariable region of RSV-A strain A2 G protein. The alignment was done by the Clustal W
method running within MEGA 5.05. Identical residues are identified as dots. Asterisks indicate the positions of stop codons. The 23 amino acid
duplication is enclosed in open boxes. Predicted N-glycosylation sites are shaded in gray. Predicted O-glycosylation sites in RSV-A strain A2 are
indicated by small unfilled circles. When compared to the NA1 reference strain, conserved O-glycosylation sites are indicated by black circles.
doi:10.1371/journal.pone.0032807.g001
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greater than 50% (Table 1).
Comparison of viral RNA secondary structures
Three sequences, NA1 (AB470478), ON1 (ON67-1210A) and
rON1 (a virtual ON1 strain without the duplication region) were
compared to provide insight into the possible mechanisms of the
duplication occurrence. When compared to their respective cRNA
structures, higher free energies (2DG in kilocalories per mole) were
observed with the viral RNA secondary structures of the NA1
reference (247.82 vs. 25.32), ON1 (280.83 vs. 223.84) and rON1
(245.57 vs.212.49) (Figure 4). Different secondary structures were
formed for NA1 and rON1 even though they display a sequence
similarity of 95.8%. By comparative structural analyses we noticed
the formation of a stable stem loop structure (SLS) at nucleotides
849 and 850 in rON1 that was not found in NA1 or ON1. Of note,
the duplication in ON1 begins immediately after nucleotide 850. In
addition, a 7nt motif (repeat motif), GUGUGUU (nucleotides 772
to 778), was observed in rON1 immediately preceding the first copy
of the duplication (Figure 4).
The ‘mfg’ program reports the most stable SLS for a given
window size of nucleotides and assumes that each SLS has to be
initiated from an unpaired base. Table 2 shows the percent unpaired
and free energy for the bases found within the repeat motif
(GUGUGUU)and atthebaseofthestableSLS(nucleotides849and
850) (in rON1 only) that precedes the duplication event. As shown in
Table 2, nucleotides 849 and 850 exhibited a very low percentage of
unpairdness in all simulations, i.e. 6% and 3%, respectively.
Discussion
In this study we analyzed G and F genes of 112 RSV-A isolates
from clinical samples tested during winter 2010–2011 in Ontario,
Canada. All sequences were analyzed using various bioinformatics
methods in order to better understand the genotype variability,
molecular epidemiology and evolutionary adaptability of circulat-
ing strains. We documented circulation of two genotypes of NA1
(89% of RSV-A isolates) and GA5 (1.8% of RSV-A isolates) in
Ontario during winter 2010–2011. In addition, 11 (10%) of the
RSV-A isolates belonged to a novel genotype, ON1, characterized
by a 72nt duplication in the C terminal third of the G gene. Our
findings differ from an earlier Canadian study, which documented
a high prevalence of GA5 and GA7 genotypes among Winnipeg
isolates in 2000, with each accounting for 30% of circulating RSV-
A isolates at that time [11]. We also observed the trend of co-
circulation of several genotypes during one single season as
previously documented [3,10,33]. Our data suggest that NA1
viruses recently circulating in Ontario are closely related to
genotype NA1 which originated in East Asia and spread
throughout the world [13]. However, due to the absence of
genotyping data from past years in Canada, we were not able to
confirm neither the direct migration between continents nor
estimate the evolutionary rate for these isolates.
We identified a novel genotype of RSV-A (ON1), with a 72
nucleotide duplication in the C terminal third of the G gene. This
duplication resulted in codon disruption and lengthening of the
subsequent predicted polypeptide by 24 AAs, including 23
duplicated AAs. Nucleotide duplications have rarely been reported
in wild type populations of RSV [15,34,35]. Such a large
duplication has not been documented in any previously described
insertion event; the largest reported to date was a 60nt duplication
in RSV-B in Buenos Aires in 1999 [15,17].
Although the sequence composition among the novel RSV-A
ON1 genotype remained conserved, three unique substitutions
(E232G, T253K and P314L) were noted to be specific for ON1,
and not observed in other Ontario isolates. In addition, two amino
Figure 2. G protein structural features of RSV-A novel genotype, ON1. A) Schematic linear representation of the G protein primary structure
of the novel ON1 containing a 72 nucleotide insertion. The amino acid sequence between residues 260 and 298 is shown, highlighting the 72
nucleotide segment that has been duplicated (boldface). The amino acid altered by the insertion is marked with a circle and the point of insertion is
indicated by an arrow. B) The 72 nucleotide duplication is indicated by 2 horizontal solid lines below the sequences. The 24 amino acid insertion
containing the 23 AA duplication is indicated by 2 horizontal lines above the sequences. Numbers corresponding to AAs indicate that the predicted G
polypeptide is lengthened to 321 AAs. C) Graphical representation of the predicted G protein of ON1 with central conserved regions and second
variable region identified. Duplicated AA sequences are highlighted in boldface. Positively selected sites are marked with a vertical bar under the line.
doi:10.1371/journal.pone.0032807.g002
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sites also resulted in loss of two potential N-glycosylation sites
identified previously in the NA1 reference strain (AB470478). Such
changes in N-glycosylation sites of the G protein might alter the
antigenicity between the genotypes and facilitate binding of
circulating antibodies [36].
High homology among wild type NA1 genotypes in Ontario
and isolates from Genbank reveals the global distribution of this
genotype. On the contrary, the presence of ON1 genotype with a
72 nucleotide insertion in Ontario might suggest the effect of
geographical and temporal factors on the genetic evolution of
RSV-A, as previously speculated for RSV-B [37]. There is
insufficient information to make specific conclusions regarding the
exact time of appearance of this new genotype. During
preparation of this manuscript, 16 RSV-A isolates collected from
April to August, 2011 were studied, and 10 (62.5%) were found to
be the novel genotype, ON1. This finding suggests that the ON1
genotype is efficiently replicating and spreading within Ontario,
and would be confirmed by genotyping a larger number of isolates
over a longer time period. Its apparent rapid spread, and lower
prevalence (11%) when first studied during winter 2010-11
suggests that it may have only emerged in Ontario in the months
prior to winter 2010-11.
Site-specific evolutionary analysis of the C-terminal hypervari-
able region of the G protein among Ontario NA1 isolates revealed
strong evolutionary selection pressure (dN/dS=4.4), resulting in
Figure 3. Phylogenetic trees for Ontario RSV-A nucleotide sequences from (a) the second variable region of the G gene and (b)
partial F gene sequences. Reference strains representing known genotypes are indicated in bold. Isolates of ON1 genotype circulating in Ontario
are indicated by a solid square. Isolates belong to genotype GA5 are marked by an open square. Multiple sequences alignment and phylogenetic
trees were constructed using Clustal W and neighbour-joining algorithm running within MEGA 5.05 software. Tree topology was supported by
bootstrap analysis with 1000 pseudo replicate datasets. Bootstrap values greater than 50 are shown at the branch nodes. The tree was visualized
using Dendroscope software, version 2.2.1.17. The scale bar represents the number of nucleotide substitutions per site between close relatives.
doi:10.1371/journal.pone.0032807.g003
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genotype (Table 1). The high range positive selection pressure
can be explained by the immunogenic nature of the C-terminal
hypervariable region which contains multiple epitopes recognized
by both murine monoclonal antibodies and human convalescent
sera [38]. Out of 19 positive selection sites among NA1 isolates,
K233E, P234S, D237N, L265P/H, N273Y, L274P, L286P and
P290L were previously described as escape mutants selected with
specific Mabs [34,39,40,41,42] . When compared to prototype
RSV-A2, six AAs (K233E, D237N, N260S, L274P, L286P and
P290L) exhibited a ‘‘flip-flop’’ pattern. The substitutions at AAs
274 and 290 resulted in loss of group-specific and strain-specific
epitopes [40,41]. The AA 237 mutation, present in 56% of the
Ontario NA1 isolates, suggested the gain of a potential N-
glycosylation site. These reverted mutations, particularly in the
epitope regions, may decrease the antigen avidity to the current
circulating strain specific antibodies [43]. Similar observations of
the reverted mutations at 237, 274, 286, and 290 were also
reported with Brazilian RSV-A isolates using HyPhy program
[43]. Other positively selected sites, E232D/G, S250F/T,
N251G/Y, T253I/K, H266Q/Y, and Y285H, are located at
antigenic sites, whereas T249A is close to an antigenic site (250–
258) [44].
Theoretical mechanisms have been proposed for duplication
events during replication and transcription processes [45–52].
These studies identified stable RNA secondary structures and
direct repeat motifs as sites possibly contributing to the occurrence
of duplication events. Similar findings were found in this study,
with the observation of SLSs and a 7nt repeat motif in rON1
immediately preceding the duplication region (Figure 4). The
previous studies also speculated that the roles of tandem repeats
and SLSs in duplication events were independent events. We
propose that there may be a mechanism that links both of these
features to duplication events, as supported by the structural data
(Figure 4) and the ‘mfg’ output (Table 2). Several polymerases
have been shown to pause at potential DNA secondary structures
formed in large single stranded templates [53–57]. Evidence from
in vitro studies also demonstrates one form of RNA polymerase
pausing, called backtracking, where after encountering an
obstruction such as a secondary structure, the RNA polymerase
reverses its direction and relocates itself upstream [58,59]. Studies
have shown that strong pause sites occur at the base of stems in
secondary structures (SS) [55,60]. We propose that RNA-
dependent RNA polymerase (RdRp) pauses and backtracks at
bases of stable SLSs such as those at positions 849 and 850 in
rON1. This pausing and backtracking of RdRp induced by stable
stems is called ‘‘Stem-Induced Backtracking’’ [61]. After the
backward slide on the template, RdRp may reinitiate the forward
slide on the same template at a particular motif such as
GUGUGUU. It should be noted that the GUGUGUU motif
precedes the first copy of the duplicated region, suggesting that the
GUGUGUU motif might play a role as an anchor site for RdRp.
The forward slide of RdRp after backtracking may result in
reading of the same region (779–848) that has already been copied
and result in duplication of the 72nt region, as seen in ON1. Our
findings may enhance understanding of the mechanisms of
duplication events in RNA viruses in which secondary structures
and direct repeats may facilitate and direct the sliding (backward
and forward) of the RdRp along the negative-strand RNA
template during replication.
The novel RSV-A genotype (ON1) is of considerable interest
because of its 72nt duplication in the G gene C-terminal one-third
region, which is the largest duplication described to date in this
genus. This area is the target for strain specific neutralizing
antibodies and such changes in structure might alter the
immunogenicity and pathogenicity of the virus. However, further
detailed studies should be undertaken to explore pathogenicity,
transmissibility and the replication pattern of this new variant.
Table 1. Parameter estimates, dN/dS, values of log-Likelihood (l), positive selection sites, and Likelihood Ratio Tests (LRT) in the G-
gene analysis of RSV-A viruses circulating in Ontario, Canada between November 2010 and February 2011.
Model Parameter estimates dN/dS Log-likelihood(l ) Positively selected sites
a
Model comparison
(2Dl, d.f, p)
M1a v0=0
v1=1.00
p0=0.6230
(p1=0.3769)
0.377 2872.78 Not allowed M1a vs. M2a: 19.94d.f=2,
p,0.0001
M2a v0=0
v1=1.00
v2=4.2356
p0=0.6330
p1=0.1960
(p2=0.1709)
0.966 2862.81 K213E, Q218P, E232D/G, K233E, D237N, S250F/T, N251G/Y,
T253I/K, L265P/H, H266Q/Y, N273Y, L274P, Y285H
M7 p=0.0050
q=0.0066
0.355 2873.01 Not allowed M7 vs. M8: 19.56d.f=2,
p,0.0001
M8 p0=0.8400
(p1=0.1599)
p=0.0325
q=0.1281
v=4.4946
0.960 2863.23 K213E, Q218P, E232D/G, K233E, P234S,D237N,
T249A,S250F/T,N251G/Y, T253I/K, N260S, L265P/H,
H266Q/Y, N273Y, L274P, S277P, Y285H, L286P, P290L
See Methods for explanation of terms used in parameter estimates column.
Neutral models (M1a, and M7) were compared with their respective alternative (selection) models (M2a and M8), which allow v.1. Model comparison can be calculated
using 2Dl=2(l12l0)), where l1=LRT of alternative model; and l0=LRT of null model. Proportion of positively selected sites and their corresponding v-values in M2a and
M8 models are in bold. The significant P values indicated that all analyses find very strong evidence for the selection model.
aPositively selected sites using Bayes Empirical Bayes analysis [28]. Posterior probability of positively selected sites of M2a model: 50% to 74% (213, 218, 237, 285); 85%
to 94% (233, 274); and .95% (232, 250, 251, 253, 265, 266, 273). Posterior probability of positively selected sites of M8 model: 50% to 74% (213, 218, 234, 249, 260, 277,
286); 75% to 84% (237, 285); 85% to 94% (233); and .95% (232, 250, 251, 253, 265, 266, 273, 274, 290).
doi:10.1371/journal.pone.0032807.t001
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Understanding the effect of the novel RSV-A ON1 genotype 72nt
G gene duplication on fitness, virulence and transmissibility could
help predict changes in viral phenotype and immunogenicity. It
will also provide insight into vaccine potential of the G gene
protein. Continued genotyping and molecular epidemiological
surveillance of RSV are essential to further understanding RSV
Figure 4. Comparison of predicted viral RNA secondary structures of G gene. Mfold predicted viral RNA secondary structures for G-gene of
A. NA1 (AB470478); B. ON1 (ON67-1210A); C. rON1, a virtual ON1 strain without the 72nt duplication. The boxed figure corresponds to the stem loop
structure (SLS) implicated in RdRp pausing at nucleotides 849 and 850. DG indicates the minimum free energy values (kilocalories per mole).
doi:10.1371/journal.pone.0032807.g004
Table 2. Percentage of nucleotide unpairdness in the region of the 7nt repeat motif at nucleotides 772–778 and 849–850 in RSV-A
ON1, rON1 and the reference strain, NA1.
Position Base NA1 (AB470478) rON1, a virtual ON1 strain (without duplication region). ON1 (ON67-1210A, with duplication region)
%unpaired base %unpaired DG fold (SI-B) base %unpaired
772 G 100 G 86 27.3 G 86
773 U 100 U 100 27.3 U 100
774 G 100 G 100 27.3 G 100
775 U 100 U 100 27.3 U 100
776 G 100 G 100 27.3 G 100
777 U 100 U 80 27U 8 0
778 U 100 U 80 26.8 U 80
849 G 43 G 6 20.9 820–849 - 66
850 C 30 C 3 20.3 821–850 C 50
DG Gibbs free energy.
SI-B stem induced backtracking.
doi:10.1371/journal.pone.0032807.t002
A Novel Genotype of HRSV A in Ontario, Canada
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e32807evolution and transmission in communities and healthcare
settings.
Acknowledgments
We acknowledge the assistance of Public Health Ontario Laboratory Virus
Detection staff who performed viral cultures, and Andrew Rimkus for
assistance with preparation of manuscript figures.
Author Contributions
Conceived and designed the experiments: AE JBG. Performed the
experiments: AE RL AL. Analyzed the data: AE VRD. Contributed
reagents/materials/analysis tools: AE RL JTN AL SNP VRD DEL JBG.
Wrote the paper: AE VRD JBG.
References
1. Sullender WM, Mufson MA, Prince GA, Anderson LJ, Wertz GW (1998)
Antigenic and genetic diversity among the attachment proteins of group A
respiratory syncytial viruses that have caused repeat infections in children. The
Journal of Infectious Diseases 178;4): 925–32.
2. Beem M (1967) Repeated infections with respiratory syncytial virus. Journal of
Immunology 98(6): 1115–22.
3. Cane PA (2001) Molecular epidemiology of respiratory syncytial virus. Reviews
in Medical Virology 11(2): 103–16.
4. Anderson LJ, Hierholzer JC, Tsou C, Hendry RM, Fernie BF, et al. (1985)
Antigenic characterization of respiratory syncytial virus strains with monoclonal
antibodies. The Journal of Infectious Diseases 151(4): 626–33.
5. Mufson MA, Orvell C, Rafnar B, Norrby E (1985) Two distinct subtypes of
human respiratory syncytial virus. J Gen Virol 66: 2111–2124.
6. Levine S, Klaiber-Franco R, Paradiso PR (1987) Demonstration that
glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen
Virol 68: 2521–2524.
7. Walsh EE, Hruska J (1983) Monoclonal antibodies to respiratory syncytial virus
proteins: Identification of the fusion protein. J Virol 47: 171–177.
8. Collins PL, Chanock RM, Murphy BR (2001) Fields virology, 4th ed. Lippincott
Williams & Wilkins, Philadelphia, PA. pp 1443–1485.
9. Sullender WM (2000) Respiratory syncytial virus genetic and antigenic diversity.
Clin Microbiol Rev 13: 1–15.
10. Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ (1998) Circulation
patterns of genetically distinct group A and B strains of human respiratory
syncytial virus in a community. J Gen Virol 79: 2221–2229.
11. Peret TC, Hall CB, Hammond GW, Piedra PA, Storch GA, et al. (2000)
Circulation patterns of group A and B human respiratory syncytial virus
genotypes in 5 communities in North America. J Infect Dis 181: 1891–1896.
12. Venter M, Madhi SA, Tiemessen CT, Schoub BD (2001) Genetic diversity and
molecular epidemiology of respiratory syncytial virus over four consecutive
seasons in South Africa: Identification of new subgroup A and B genotypes.
J Gen Virol 82: 2117–2124.
13. Shobugawa Y, Saito R, Sano Y, Zaraket H, Suzuki Y, et al. (2009) Emerging
genotypes of human respiratory syncytial virus subgroup A among patients in
Japan. J Clin Microb 47: 2475–2482.
14. Trento A, Viegas M, Galiano M, Videla C, Carballal G, et al. (2006) Natural
history of human respiratory syncytial virus inferred from phylogenetic analysis
of the attachment (G) glycoprotein with a 60-nucleotide duplication. J Virol 80:
975–984.
15. Trento A, Galiano M, Videla C, Carballal G, Garcia-Barreno B, et al. (2003)
Major changes in the G protein of human respiratory syncytial virus isolates
introduced by a duplication of 60 nucleotides. J Gen Virol 84: 3115–3120.
16. Sato M, Saito R, Sakai T, Sano Y, Nishikawa M, et al. (2005) Molecular
epidemiology of respiratory syncytial virus infections among children with acute
respiratory symptoms in a community over three seasons. J Clin Microb 43:
36–40.
17. Dapat IC, Shobugawa Y, Sano Y, Saito R, Sasaki A, et al. (2010) New genotypes
within respiratory syncytial virus group B genotype BA in Niigata, Japan. J Clin
Microb 48: 3423–3427.
18. Johnson PR, Spriggs MK, Olmsted RA, Collins PL (1987) The G glycoprotein
of human respiratory syncytial viruses of subgroups A and B: Extensive sequence
divergence between antigenically related proteins. Proc Natl Acad Sci U S A 84:
5625–5629.
19. Lambert DM (1988) Role of oligosaccharides in the structure and function of
respiratory syncytial virus glycoproteins. Virology 164: 458–66.
20. Garcia-Beato R, Martinez I, Franci C, Real FX, Garcia-Barreno B, et al. (1996)
Host cell effect upon glycosylation and antigenicity of human respiratory
syncytial virus G glycoprotein. Virology 221: 301–309.
21. Dewhurst-Maridor G, Simonet V, Bornand JE, Nicod LP, Pache JC (2004)
Development of a quantitative TaqMan RT-PCR for respiratory syncytial virus.
J Virol Methods 120: 41–49.
22. Sullender WM, Sun L, Anderson LJ (1993) Analysis of respiratory syncytial virus
genetic variability with amplified cDNAs. J Clin Microb 31: 1224–1231.
23. Parveen S, Sullender WM, Fowler K, Lefkowitz EJ, Kapoor SK, et al. (2006)
Genetic variability in the G protein gene of group A and B respiratory syncytial
viruses from India. J Clin Microb 44: 3055–3064.
24. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5:
Molecular evolutionary genetics analysis using maximum likelihood, evolution-
ary distance, and maximum parsimony methods Mol Biol Evol (In press).
25. Kimura M (1980) A simple method for estimating evolutionary rate of base
substitutions through comparative studies of nucleotide sequences. J Mol Evol
16: 111–120.
26. Yang Z (1997) PAML: A program package for phylogenetic analysis by
maximum likelihood. Computer Applications in the Biosciences: CABIOS 13:
555–6.
27. Yang Z (2007) PAML 4: a program package for phylogenetic analysis by
maximum likelihood. Mol Biol Evol 24: 1586–1591.
28. Yang Z, Wong WS, Nielsen R (2005) Bayes empirical bayes inference of amino
acid sites under positive selection. Mol Biol Evol 22: 1107–1118.
29. Gupta R, Jung E, Brunak S (2004) Prediction of N-glycosylation sites in human
proteins. NetNGlyc 1.0. (NetNGlyc website. Available: http://www.cbs.dtu.dk/
services/NetNGlyc/Accessed on 2012 Feb 07.).
30. Julenius K, Molgaard A, Gupta R, Brunak S (2005) Prediction, conservation
analysis, and structural characterization of mammalian mucin-type O-
glycosylation sites. Glycobiology 15: 153–164.
31. Zuker M, Mathews DM, Turner DH (1999) Algorithms and Thermodynamics
for RNA Secondary Structure Prediction: A Practical Guide in RNA
Biochemistry and Biotechnology. Barciszewski J and Clark BFC, editors.
NATO ASI Series, Kluwer Academic Publishers, Dordrecht, NL. pp 11–43.
32. Wright BE, Reschke DK, Schmidt KH, Reimers JM, Knight W (2003)
Predicting mutation frequencies in stem-loop structures of derepressed genes:
implications for evolution. Mol Microb 48: 429–441.
33. Hall CB, Walsh EE, Schnabel KC, Long CE, McConnochie KM, et al. (1990)
Occurrence of groups A and B of respiratory syncytial virus over 15 years:
Associated epidemiologic and clinical characteristics in hospitalized and
ambulatory children. J Infect Dis 162: 1283–1290.
34. Garcia O, Martin M, Dopazo J, Arbiza J, Frabasile S, et al. (1994) Evolutionary
pattern of human respiratory syncytial virus (subgroup A): Cocirculating lineages
and correlation of genetic and antigenic changes in the G glycoprotein. J Virol
68: 5448–5459.
35. Zlateva KT, Lemey P, Moes E, Vandamme AM, Van Ranst M (2005) Genetic
variability and molecular evolution of the human respiratory syncytial virus
subgroup B attachment G protein. J Gen Virol 79: 9157–9167.
36. Cane PA, Matthews DA, Pringle CR (1994) Analysis of respiratory syncytial
virus strain variation in successive epidemics in one city. J Clin Microb 32: 1–4.
37. Kuroiwa Y, Nagai K, Okita L, Yui I, Kase T, et al. (2005) A phylogenetic study
of human respiratory syncytial viruses group A and B strains isolated in two cities
in Japan from 1980–2002. J Med Virol 76: 241–247.
38. Melero JA, Garcia-Barreno B, Martinez I, Pringle CR, Cane PA (1997)
Antigenic structure, evolution and immunobiology of human respiratory
syncytial virus attachment (G) protein. J Gen Virol 78: 2411–2418.
39. Cane PA, Pringle CR (1995) Evolution of subgroup A respiratory syncytial virus:
Evidence for progressive accumulation of amino acid changes in the attachment
protein. J Virol 69: 2918–2925.
40. Martinez I, Dopazo J, Melero JA (1997) Antigenic structure of the human
respiratory syncytial virus G glycoprotein and relevance of hypermutation events
for the generation of antigenic variants. J Gen Virol 78: 2419–2429.
41. Lazar I, Canaan A, Weibel C, Kahn JS (2006) Novel mutations in the
respiratory syncytial virus G gene identified in viral isolates from a girl with
severe combined immune deficiency treated with intravenous immune globulin.
J Clin Virol 37: 168–173.
42. Galiano MC, Palomo C, Videla CM, Arbiza J, Melero JA, et al. (2005) Genetic
and antigenic variability of human respiratory syncytial virus (groups a and b)
isolated over seven consecutive seasons in Argentina (1995 to 2001). J Clin
Microb 43: 2266–2273.
43. Botosso VF, Zanotto PM, Ueda M, Arruda E, Gilio AE, et al. (2009) Positive
selection results in frequent reversible amino acid replacements in the G protein
gene of human respiratory syncytial virus. PLoS Pathogens 5: e1000254.
44. Cane PA (1997) Analysis of linear epitopes recognised by the primary human
antibody response to a variable region of the attachment (G) protein of
respiratory syncytial virus. J Med Virol 51: 297–304.
45. Kirkegaard K, Baltimore D (1986) The mechanism of RNA recombination in
poliovirus. Cell 47: 433–443.
46. Scott GE, Tarlow O, McCrae MA (1989) Detailed structural analysis of a
genome rearrangement in bovine rotavirus. Virus Res 14: 119–127.
47. Gault E, Schnepf N, Poncet D, Servant A, Teran S, et al. (2001) A human
rotavirus with rearranged genes 7 and 11 encodes a modified NSP3 protein and
suggests an additional mechanism for gene rearrangement. J Virol 75:
7305–7314.
A Novel Genotype of HRSV A in Ontario, Canada
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e3280748. Matthijnssens J, Rahman M, Van Ranst M (2006) Loop model: mechanism to
explain partial gene duplications in segmented dsRNA viruses. Biochem Biophys
Res Commun 340: 140–144.
49. Ballard A, McCrae MA, Desselberger U (1992) Nucleotide sequences of normal
and rearranged RNA segments 10 of human rotaviruses. The J Gen Virol 73:
633–638.
50. Kojima K, Taniguchi K, Kawagishi-Kobayashi M, Matsuno S, Urasawa S
(2000) Rearrangement generated in double genes, NSP1 and NSP3, of viable
progenies from a human rotavirus strain. Virus Res 67: 163–171.
51. Wilson V, Taylor P, Desselberger U (1988) Crossover regions in foot-and-mouth
disease virus (FMDV) recominants correspond to regions of high local secondary
structure. Arch Virol 102: 131–139.
52. Gorziglia M, Nishikawa K, Fukuhara N (1989) Evidence of duplication and
deletion in super short segment 11 of rabbit rotavirus Alabama strain. Virology
170: 587–590.
53. Kaguni LS, Clayton DA (1982) Template-directed pausing in in vitro DNA
synthesis by DNA polymerase a from Drosophila melanogaster embryos. Proc
Natl Acad Sci U S A 79: 983–987.
54. Weaver DT, DePamphilis ML (1982) Specific sequences in native DNA that
arrest synthesis by DNA polymerase alpha. J Biol Chem 257: 2075–2086.
55. Weaver DT, DePamphilis ML (1984) The role of palindromic and non-
palindromic sequences in arresting DNA synthesis in vitro and in vivo. J Mol
Biol 180: 961–986.
56. LaDuca RJ, Fay PJ, Chuang C, McHenry CS, Bambara RA (1983) Site-specific
pausing of deoxyribonucleic acid synthesis catalyzed by four forms of
Escherichia coli DNA polymerase III. Biochemistry 22: 5177–5188.
57. Bedinger P, Munn M, Alberts BM (1986) Sequence-specific pausing during in
vitro DNA replication on double-stranded DNA templates. J Biol Chem 264:
16880–16886.
58. Galburt EA, Grill SW, Wiedmann A, Lubkowska L, Choy J, et al. (2007)
Backtracking determines the force sensitivity of RNAP II in a factor-dependent
manner. Nature 446: 820–823.
59. Komissarova N, Kashlev M (1997) Transcriptional arrest: Escherichia coli RNA
polymerase translocates backward, leaving the 39 end of the RNA intact and
extruded. Proc Natl Acad Sci U S A 94: 1755–1760.
60. Suo Z, Johnson KA (1998) DNA secondary structure effects on DNA synthesis
catalyzed by HIV-1 reverse transcriptase. J Biol Chem 273: 27259–27267.
61. Shaevitz JW, Abbondanzieri EA, Landick R, Block SM (2003) Backtracking by
single RNA polymerase molecules observed at near-base-pair resolution. Nature
426: 684–687.
A Novel Genotype of HRSV A in Ontario, Canada
PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e32807